Rationale for combination therapy of intraurethral prostaglandin E1 and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy

International Journal of Impotence Research

Volumn 14, Issue , 2002, Pages S38-S42

  Nehra, A ^a   Blute, M L ^a   Barrett, D M ^b   Moreland, R B ^c,d  

^a DEPARTMENT OF UROLOGY   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ABBOTT LABORATORIES   (United States)

Author keywords

Cyclic adenosine monophosphate; Cyclic guanosine monophosphate; Minimally invasive therapy; MUSE; Prostaglandin E1; Radical prostatectomy; Sildenafil

Indexed keywords

CYCLIC AMP; CYCLIC GMP; PROSTAGLANDIN E1; SILDENAFIL;

ADULT; AGED; CAVERNOSOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CORPUS CAVERNOSUM; DOPPLER FLOWMETRY; DRUG EFFICACY; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; MALE; PENIS ERECTION; PRIORITY JOURNAL; PROSTATECTOMY; RISK FACTOR; SEXUAL INTERCOURSE; SMOOTH MUSCLE RELAXATION; TREATMENT FAILURE; TREATMENT OUTCOME; VASODILATATION;

AGED; ALPROSTADIL; COHORT STUDIES; CYCLIC AMP; CYCLIC GMP; DRUG THERAPY, COMBINATION; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; MUSCLE, SMOOTH; PATIENT SATISFACTION; PIPERAZINES; PROSTATECTOMY; URETHRA; VASODILATOR AGENTS;

EID: 0036195280     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900795     Document Type: Article

References (19)

1. Pharmacotherapeutic advances in the treatment of erectile dysfunction
2. Oral sildenafil in the treatment of erectile dysfunction
3. Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury
4. A two-part study of sildenafil (Viagra™) in men with erectile dysfunction caused by spinal cord injury
5. Sildenafil for treatment of erectile dysfunction in men with diabetes: A randomized controlled trial
6. Treatment of erectile dysfunction with sildenafil
7. A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil
8. Treatment of men with erectile dysfunction with transurethral alprostadil
9. Oxygen-dependent prostanoid synthesis activates functional PGE receptors on human corpus cavernosum smooth muscle cells
10. In vivo assessment of trabecular smooth muscle tone, its application in pharmacocavernosometry and analysis of intracavernosal pressure determinants
11. Transurethral alprostadil with MUSE™ (medicated urethral system for erection) vs intracavernous Alprostadil: A comparative study in 103 patients with erectile dysfunction
12. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)
13. MUSE™ therapy: Preliminary clinical observations
14. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting
15. Effectiveness of combination therapy of MUSE™ and Viagra™ in the salvage of erectile dysfunction patients desiring noninvasive therapy
16. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells
17. Repeated PGE1 treatment enhances nitric oxide and erection responses to nerve stimulation in the rat penis by upregulating constitutive NOS isoforms
18. 1 alpha 1D and alpha 2A adrenergic receptors in cultured human corpus cavernosum smooth muscle cells
19. The role of prostaglandin E as determined by expression of functional prostaglandin E receptors in human corpus cavernosum